Dissecting Cell Type Specific Functions of CHD7 in Development of the Neocortex
剖析 CHD7 在新皮质发育中的细胞类型特异性功能
基本信息
- 批准号:10732823
- 负责人:
- 金额:$ 56.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAcuteAffectAnimal ModelAnteriorBehavioralBrainBrain DiseasesCHARGE syndromeCHD7 geneCell Differentiation processCell physiologyCellsCellular biologyChIP-seqChromatinChromatin StructureCognitiveConfocal MicroscopyDataDevelopmentDevelopmental ProcessDiseaseElectrophysiology (science)EmbryoEnhancersExcitatory SynapseExecutive DysfunctionExhibitsFunctional disorderGene DeletionGene ExpressionGene MutationGenesGeneticGenetic TranscriptionGenomicsGrowthHeterozygoteHumanIn Situ HybridizationInhibitory SynapseKnowledgeLinkMethodsMolecularMusMutateMutationNeocortexNeurodevelopmental DisorderNeuronsPathogenicityPatternPhenotypePhysiologic pulsePhysiologyPopulationPrefrontal CortexProcessProliferatingProteinsRegulatory ElementReportingResearchReverse Transcriptase Polymerase Chain ReactionRoleSliceStudy modelsSynapsesSyndromeTestingTimeVariantVisualVisual CortexVisualizationWild Type MouseWorkarea striataautism spectrum disordercell typechromatin remodelingdevelopmental diseasedigitalexcitatory neuronexperimental studyindividuals with autism spectrum disorderinhibitory neuroninnovationmultiple omicsneocorticalnerve stem cellneurogenesisneuropsychiatric disordernext generation sequencingoverexpressionpatch clamppostnatalprogenitorsexstem cell proliferationsynaptogenesistargeted treatmenttooltranslational model
项目摘要
PROJECT SUMMARY/ABSTRACT
The aim of this proposal is to determine how heterozygous mutation of the chromatin remodeler CHD7
(Chromodomain Helicase DNA-binding protein 7) disrupts development of the neocortex, leading to the
neurodevelopmental anomalies associated with CHARGE syndrome. CHARGE syndrome is characterized by
substantial behavioral and cognitive problems, including executive dysfunction and Autism Spectrum Disorder
(ASD). The proposed research team recently identified abnormalities in the neocortex of Chd7 heterozygous
mice, implicating CHD7 in key, temporally distinct developmental processes. Preliminary data suggest that
anterior-posterior (A-P) patterning of the neocortex is disrupted in these mice and that CHD7 directly regulates
the expression of a master regulator of A-P patterning, Nr2f1 (COUP-TF1). These mice also exhibit cortical
hypoplasia, implicating Chd7 in cortical growth. Furthermore, excitatory and inhibitory synapses onto deep layer
principal neurons of the prefrontal cortex (PFC) are affected by Chd7 haploinsufficiency. Both executive
dysfunction and ASD have been linked to PFC dysfunction. Thus, these findings provide the long-sought
opportunity to identify the mechanisms whereby CHD7 haploinsufficiency disrupts neocortical development.
Chd7 function is context-dependent; hence, a significant focus will be to define sex-, region- and cell-type-specific
functions and mechanisms. This project's specific aims are to 1) test the hypothesis that Chd7 haploinsufficiency
disrupts A-P patterning of the neocortex, 2) define the molecular and cellular functions of Chd7 in neural
stem/progenitor cells of the neocortex and subpallium and 3) test the hypothesis that Chd7 has cell-type-specific
functions in the development of synapses in the PFC. The team will use standard and innovative methods to
visualize and quantify the expression patterns and levels of markers of A-P patterning, and quantify region-, cell-
and sex-specific abnormalities in excitatory and inhibitory neurogenesis. Bulk and single cell next generation
sequencing approaches will be used to identify transcriptional and chromatin changes in different regions and
cell types of the Chd7-deficient developing neocortex in both sexes. The multi-institute team brings together
expertise in neurodevelopmental functions of CHD proteins (Basson), translational and modeling studies of
CHARGE syndrome (Martin), genomics of cortical development (Kwan), and synapse physiology (Andreae).
Together, this work will provide a comprehensive understanding of the impacts of CHD7 haploinsufficiency on
multiple processes in development of the neocortex and identify cell-type-specific functions for CHD7 in neural
progenitor differentiation and PFC circuit assembly. Successful completion of this work will generate the
knowledge and tools necessary to identify the neurodevelopmental mechanisms and circuits that underlie
specific behavioral and cognitive phenotypes associated with CHARGE syndrome and other related disorders.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura Andreae其他文献
Laura Andreae的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 56.21万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 56.21万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 56.21万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 56.21万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 56.21万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 56.21万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 56.21万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 56.21万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 56.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 56.21万 - 项目类别:
Operating Grants














{{item.name}}会员




